论文部分内容阅读
目的:探究血府逐瘀汤合小青龙汤治疗慢性肺源性心脏病急性加重期的临床效果。方法:选取2014年3月-2016年3月收治的120例慢性肺源性心脏病急性加重期患者作为观察对象,随机分为对照组和观察组各60例,所有患者均采用西医常规治疗,即给予低流量吸氧,服用抗炎、扩血管以及利尿药物。观察组在此基础上合用血府逐瘀汤合小青龙汤治疗。观察两组患者的心肺功能指标水平及总有效率。结果:观察组总有效率为95.00%,高于对照组的78.33%(P<0.05);观察组在用力呼吸量/用力肺活量(FEV/FVC)以及1秒用力呼吸容积(FEV1)的肺通气功能指标水平方面明显高于对照组,而右室内径和脉动脉压力的心功能指标低于对照组,两组对比差异有统计学意义(P<0.05)。结论:血府逐瘀汤合小青龙汤能有效缓解慢性肺源性心脏病急性加重期患者的临床症状,改善心肺功能。
Objective: To investigate the clinical effect of Xuefuzhuyu Decoction combined with Xiaoqinglong Decoction in the treatment of acute exacerbation of chronic cor pulmonale. Methods: A total of 120 patients with acute exacerbation of chronic cor pulmonale who were admitted to our hospital from March 2014 to March 2016 were selected as observation subjects and randomly divided into control group and observation group of 60 patients. All patients were treated with routine western medicine, That is given low-flow oxygen, taking anti-inflammatory, vasodilator and diuretic drugs. On the basis of the observation group, Xuefu Zhuyu Decoction and Xiaoqinglong Decoction were used together. The cardiopulmonary function index and total effective rate of the two groups were observed. Results: The total effective rate in the observation group was 95.00%, which was significantly higher than that in the control group (78.33%, P <0.05). In the observation group, the pulmonary ventilation in forced vital capacity (FEV / FVC) and forced expiratory volume The level of functional index was significantly higher than that of the control group, while the indexes of cardiac function of the right ventricular internal diameter and pulse pressure were lower than those of the control group. There was significant difference between the two groups (P <0.05). Conclusion: Xuefuzhuyu Decoction combined Xiaoqinglong Decoction can effectively relieve the clinical symptoms of patients with acute exacerbation of chronic cor pulmonale and improve cardiopulmonary function.